A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)
Clinical trial NCT00812331 · COMPLETED
Trial details
- NCT number
- NCT00812331
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-11-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.